TAYEBATI, Seyed Khosrow
 Distribuzione geografica
Continente #
NA - Nord America 24.256
AS - Asia 13.345
EU - Europa 13.294
SA - Sud America 1.350
Continente sconosciuto - Info sul continente non disponibili 925
AF - Africa 352
OC - Oceania 41
Totale 53.563
Nazione #
US - Stati Uniti d'America 23.217
CN - Cina 5.198
SG - Singapore 3.326
RU - Federazione Russa 2.916
IT - Italia 2.817
HK - Hong Kong 2.086
PL - Polonia 1.772
BR - Brasile 1.113
FR - Francia 1.072
UA - Ucraina 1.051
DE - Germania 1.043
VN - Vietnam 874
CA - Canada 817
SE - Svezia 776
GB - Regno Unito 606
FI - Finlandia 511
TR - Turchia 441
KR - Corea 424
IE - Irlanda 251
ZA - Sudafrica 232
IN - India 213
BD - Bangladesh 164
MX - Messico 133
NL - Olanda 126
AR - Argentina 74
IQ - Iraq 70
JP - Giappone 69
IR - Iran 65
PK - Pakistan 62
CH - Svizzera 56
CZ - Repubblica Ceca 55
ID - Indonesia 54
EU - Europa 44
ES - Italia 42
EC - Ecuador 37
AU - Australia 35
MY - Malesia 35
CO - Colombia 33
BE - Belgio 32
GR - Grecia 31
MA - Marocco 31
SA - Arabia Saudita 29
UZ - Uzbekistan 29
PE - Perù 24
AE - Emirati Arabi Uniti 23
TW - Taiwan 23
CL - Cile 21
JM - Giamaica 21
LT - Lituania 21
VE - Venezuela 21
AT - Austria 20
PH - Filippine 20
EG - Egitto 18
TH - Thailandia 17
CR - Costa Rica 16
RO - Romania 16
NP - Nepal 15
IL - Israele 14
AZ - Azerbaigian 13
DZ - Algeria 13
PY - Paraguay 13
JO - Giordania 12
TN - Tunisia 12
AL - Albania 11
TT - Trinidad e Tobago 11
EE - Estonia 10
KZ - Kazakistan 10
UY - Uruguay 10
DK - Danimarca 9
HU - Ungheria 8
PA - Panama 8
GH - Ghana 7
HN - Honduras 7
KE - Kenya 7
KG - Kirghizistan 7
NG - Nigeria 7
NO - Norvegia 7
RS - Serbia 7
LB - Libano 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
GE - Georgia 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
NZ - Nuova Zelanda 5
OM - Oman 5
BO - Bolivia 4
GA - Gabon 4
KH - Cambogia 4
LV - Lettonia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
CM - Camerun 3
CY - Cipro 3
ET - Etiopia 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 52.631
Città #
Jacksonville 2.198
Hong Kong 2.058
Ashburn 1.852
Warsaw 1.572
Singapore 1.512
San Jose 1.352
Fairfield 1.322
Council Bluffs 1.302
Chandler 1.230
Woodbridge 1.163
Boardman 1.014
Houston 915
Wilmington 786
Beijing 690
Ann Arbor 626
Seattle 595
Nanjing 585
Toronto 570
The Dalles 497
Cambridge 448
Los Angeles 387
Seoul 372
Tongling 348
Istanbul 344
Lawrence 336
Princeton 336
San Mateo 331
Shanghai 312
Columbus 307
Lauterbourg 301
Camerino 298
Helsinki 290
Ho Chi Minh City 273
New York 273
Ogden 271
Dearborn 240
Dublin 235
St Louis 235
Dallas 232
Nanchang 226
Johannesburg 206
Centro 188
Guangzhou 182
Buffalo 168
Dong Ket 160
Moscow 160
Santa Clara 159
Trieste 156
Hanoi 151
Zhengzhou 147
Kraków 146
Milan 143
Rome 135
Jiaxing 134
Shenyang 119
Kunming 116
Lachine 112
London 110
Chicago 108
Orem 108
Düsseldorf 107
São Paulo 105
Munich 101
Tianjin 97
Hebei 90
Redondo Beach 89
Philadelphia 86
Bremen 76
Wuhan 76
Frankfurt am Main 71
Redwood City 69
Changsha 66
Hangzhou 65
Phoenix 65
Atlanta 61
Chennai 60
Tokyo 59
Denver 58
San Diego 57
Montreal 55
Jinan 54
Mexico City 54
Vinnytsia 54
Rio de Janeiro 52
Basingstoke 45
Falls Church 45
Kocaeli 44
Brooklyn 43
Hefei 43
Norwalk 43
Shenzhen 42
Manchester 40
Stockholm 38
Lanzhou 37
San Francisco 37
Detroit 36
Mumbai 36
Orange 34
Verona 34
Naples 33
Totale 33.499
Nome #
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children. 1.204
Effetti neuroprotettivi del Nerve Growth Factor somministrato come collirio in bambini e giovani adulti con deficits visivi indotti da gliomi delle vie ottiche 776
A multidisciplinary approach to study the brain injury in Diet-Induced (DIO) rats 516
Metabolic effects of tart Cherries Supplementation in an animal model of obesity 473
Anatomia del Gray, I Fondamenti 442
Neurological Disorder, Stroke: Relevance of Preclinical Studies 393
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain 373
Effects of Tart Cherry supplementation in Diet-Induced Obesity (DIO) rats. 365
Obesity-related nervous system injury: preliminary evidences in diet induced obesity (DIO) rats. 354
Telerehabilitation: Review of the State-of-the-Art and Areas of Application 348
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 343
Obesity affects central nervous system: a multidisciplinary study in Diet-Induced Obesity (DIO) rats 322
EXPRESSION OF SINAPTO-VESICULAR PROTEINS IN BRAIN AREAS OF AN ANIMAL MODEL OF METABOLIC SYNDROME 320
Frontiers in Molecular Biosciences 318
Process mining case study approach: Extraction of unconventional event logs to improve performance in Hospital Information Systems (HIS) 318
Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study 317
Identification of World Health Organisation ship's medicine chest contents by Anatomical Therapeutic Chemical (ATC) classification codes. 314
THE OBESE ZUCKER RATS: AN IN VIVO MODEL FOR STUDYING THE LIVER CARBONIC ANHYDRASE CAVII BIOLOGICAL ROLE 299
Brain alterations in high fat diet induced obesity: Effects of tart cherry seeds and juice 275
Brain Activity of Thioctic Acid Enantiomers: In Vitro and in Vivo Studies in an Animal Model of Cerebrovascular Injury 268
ACETYLCHOLINE PRECURSORS ATTENUATE NEUROINFLAMMATION IN LPS-STIMULATED BV2 CELLS 259
Comparative analysis of the medicinal compounds of the ship's "medicine chests" in European Union maritime countries. Need for improvement and harmonization 258
Guida alla Farmacia di Bordo 257
Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. 255
Adrenergic receptor subtypes in human peripheral blood lymphocytes. 253
Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats. 252
Editorial Board of Neurosurgery Cases and Reviews 249
OBESITY-RELATED CEREBROVASCULAR INJURY IN OBESE ZUCKER RATS 247
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 247
Comparative machine-learning approach: A follow-up study on type 2 diabetes predictions by cross-validation methods 247
Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study. 245
Report on market analysis and preventions need to provide medications for rural patients of Italy using ICT technologies 244
Effects of acetylcholine precursors on inflammation in rat brain 241
PROTECTIVE ACITIVITY OF THE CHOLINE CONTAINING PHOSPHOLIPID CHOLINE ALPHOSCERATE, ON CEREBROVASCULAR TREE OF SPONTANEOUSLY HYPERTENSIVE RATS 239
Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate. 234
A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor. 232
Effects of Prunus cerasus L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity 231
Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor 228
Discovery of Highly Selective Imidazoline Receptor Ligands 228
(Neuro)transmitter systems in circulating immune cells: a target of immunopharmacological interventions? 226
THE PHARMACIST KNOWLEDGE AND COMPUTER SKILLS TOWARDS E-HEALTH. RESULTS OF A SURVEY AMONG ITALIAN COMMUNITY PHARMACISTS 226
ACTIVITY OF THIOCTIC ACID ENANTIOMERS ON SPINAL CORD CHANGES CONSEQUENT TO PERIPHERAL NERVE INJURY 221
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes 218
Age-related changes in the brain of obese Zucker rat: Morphological and immunochemical analysis. 217
Obesity-related blood brain barrier changes in obese Zucker rats 216
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook. 214
Brain cholinergic dysfunction in obese Zucker LEPR(fa/fa) rats 214
Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells 213
Policies and challenges on the distribution of specialists and subspecialists in rural areas of Iran 213
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 212
Ein neues klinisches Syndrom bedingt durch eine Defizienz des muskarinergen M3-Rezeptors: Trias aus bilateraler Mydriasis, Blasenentleerungsstörung und schlankem Habitus 211
Anti-Inflammatory and Antioxidant Properties of Tart Cherry Consumption in the Heart of Obese Rats 206
ACTIVITY OF CHOLINE ALPHOSCERATE ON CEREBROVASCULAR MORPHOLOGY AND INFLAMMATORY MARKERS IN SPONTANEOUSLY HYPERTENSIVE RATS 206
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission 204
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 202
Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats. 201
Occupancy by oral administration of nicardipine of L-type calcium channels in rat brain 199
Dementias and cognitive disorders: New insights and approaches 199
Heart morphology in Zucker-obese rats 199
EFFECTS OF CHOLINE-ALPHOSCERATE AND THIOCTIC ACID ON THE BRAIN OF HYPERTENSIVE RATS 199
Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries 198
Cardiovascular changes related to metabolic syndrome: Evidence in obese zucker rats 197
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 196
Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. 193
Muscarinic Thioligands with Cyclopentane Nucleus 193
Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds 193
ALLA SCOPERTA DEL RUOLO DELL’INVECCHIAMENTO E DEL SESSO NEI PROCESSI DEGENERATIVI FISIOLOGICI E PATOLOGICI DEI NERVI PERIFERICI. 191
Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. 190
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 190
NEUROPLASTICITY OF ENTERIC NERVOUS SYSTEM IN ANIMAL MODEL OF OBESITY 189
Obesity and Metabolic Syndrome Affects the Cholinergic Transmission and Cognitive Functions 188
Dopamine and vascular dynamics control: present status and future perspectives. 187
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. 187
Age-related Changes in the Density of Muscarinic Cholinergic M1 and M2 Receptor Subtypes in Pyramidal Neurons or the rat Hippocampus 186
Glial fibrillary acidic protein and vimentin expression is regulated by glucocorticoids and neurotrophic factors in primary rat astroglial cultures 184
Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study 184
TREATMENT WITH A CHOLINERGIC PRECURSOR IN AN ANIMAL MODEL OF CEREBROVASCULAR DISEASE: INSIGHTS INTO MECHANISMS OF NEUROPROTECTIVE ACTIVITY 184
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 183
Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study 182
Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands 182
Influence of dermal exposure to the pyrethroid insecticide deltamethrin on rat brain microanatomy and cholinergic/dopaminergic neurochemistry. 182
Animal models of cognitive dysfunction. 181
Spontaneously hypertensive rat as a model of vascular brain disorder: Microanatomy, neurochemistry and behavior. 181
Potential dopamine-1 receptor stimulation in hypertension management. 180
BRAIN MORPHOLOGICAL ANALYSIS OF OBESE ZUCKER RAT: MODEL OF METABOLIC SYNDROME. 179
Evaluation of an Agonist Index: Affinity Ratio for Compounds Active on Muscarinic Cholinergic M2 Receptors 178
Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. 178
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 178
Dopamine receptors in human platelets. 177
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. 177
Modulation Of Monoaminergic Transporters By Choline-Containing Phospholipids In Rat Brain. 177
Member of SCIENTIFIC ADVISORY BOARD of 9th International Congress on Vascular Dementia 177
Does obesity affect the mucin secretion of the rat intestinal mucosa? 177
Batten disease through different in vivo and in vitro models: A review 177
Muscarinic cholinergic receptors subtypes in rat cerebellar cortex: light microscope autoradiography of age-related changes 176
ALPHA1-ADRENERGIC RECEPTOR SUBTYPES HUMAN PERIPHERAL BLOOD LYMPHOCYTES 174
Muscarinic cholinergic receptor subtypes in cerebral cortex of Fisher 344 rats: a light microscope autoradiography study of age-related changes. 174
Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study 173
Choline-containing phospholipids: relevance to brain functional pathways. 173
Identification of adenosine A1 and A3 receptor subtypes in rat pial and intracerebral arteries. 172
Totale 24.718
Categoria #
all - tutte 227.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.847 0 784 86 149 257 126 76 216 295 240 222 396
2022/20233.537 456 115 113 418 399 505 55 245 678 226 222 105
2023/20242.984 472 157 196 80 158 234 127 137 390 127 104 802
2024/202510.367 490 292 1.205 789 263 482 930 2.406 709 759 475 1.567
2025/202614.622 742 1.892 995 1.836 1.312 992 2.387 1.230 608 1.045 1.069 514
2026/20271.574 1.100 474 0 0 0 0 0 0 0 0 0 0
Totale 53.563